MedTrace Logo

Determination of Ustekinumab Levels in Patients With Crohn's Disease

NCT05057832 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2021-11-17

No results posted yet for this study

Summary

Observational, prospective, single-center follow-up study carried out with patients from the area of the Virgen de Macarena University Hospital, diagnosed with chronic kidney disease, who started treatment with ustekinumab.

Conditions

  • Crohn Disease

Sponsors & Collaborators

  • Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

    lead OTHER

Principal Investigators

  • Federico Arguelles Arlas · Hospital Universitario Virgen Macarena

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2022-02-01
Completion
2022-02-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05057832 on ClinicalTrials.gov